Insights filtered by:

Articles

Clear all Articles
Articles

The rise of UK wine: why intellectual property protection is a vintage necessity

As the UK wine industry continues to grow, the need to protect the unique characteristics and reputations of British wines has never been more critical. In this article, Trade Mark Attorney, Claire Bothma, explores why the UK wine industry is at a pivotal moment when it comes to IP, and details how a UK wine producer can protect a brand’s identity and competitive edge.

Read more
Articles

G1/24 referral to the Enlarged Board of Appeal (EBOA) – will the EBOA resolve the burning issue of claim interpretation?

Senior Associate, Edward Rainsford, discusses a referral brought to the Enlarged Board of Appeal. The Enlarged Board of Appeal has been presented with several questions about the extent to which the description and figures should be consulted when interpreting the claims of a patent application. The upcoming decision could clarify claim interpretation in future cases.

Read more
Articles

Clinical trials: what you can and cannot do – exemptions to patent infringement in the UK

Clinical trials in the UK are governed by what can at times appear like, a complex arrangement of provisions and exemptions. In this article, we summarise these provisions and provide a guide on how to ensure that intellectual property rights are not infringed in the process of carrying out a clinical trial.

Read more
Articles

Malaria: new vaccines hailed as a breakthrough in the fight against the disease

In this article, Appleyard Lees', Senior Associate and Patent Attorney, Sarah Gibbs, explores how the launch of two recently developed malaria vaccines, RTS,S and R21, marks a critical milestone in combating malaria. Sarah explores how integrating these vaccines with existing control measures in Africa sets out a promising path towards near-eradication of malaria.

Read more
Articles

Sanofi and Regeneron vs Amgen – UPC’s first revocation decision

The first revocation decision from the Unified Patent Court (UPC) has seen a win for Sanofi and Regeneron in a dispute with Amgen over cholesterol lowering drugs.

Read more
Articles

Innovation focus: innovative ideas to support people living with Dementia and Alzheimer’s disease

In this article, we explore and discuss emerging technological innovations designed to enhance care for individuals affected by Alzheimer's disease and dementia. Appleyard Lees supports organisations that create or enable innovation that makes life better and is proud to be supporting the UK's leading dementia charity, Alzheimer’s Society. Alzheimer’s Society are an organisation striving to eliminate the devastating impact of dementia worldwide, as our charity of the year.

Read more
Directors and IP – getting up close and personal - part 2
Articles

Directors and IP – getting up close and personal – part 2

The UK Supreme Court has provided guidance on the circumstances upon which directors may be personally liable as an accessory to a tort (trade mark infringement is a tortious act) committed by their company.

Read more
Articles

Romania joins the Unified Patent Court (UPC)

Romania deposited its instrument of ratification of the Unified Patent Court Agreement on 31 May 2024, becoming the 18th member state to ratify the Agreement.

Read more
1 / 1 – T 176221
Articles

T 1762/21 – Added matter and intermediate generalisations: when are features “inextricably linked”?

Sarah Gibbs discusses a recent decision from the European Patent Office on how intermediate generalisations should be assessed for added matter.

Read more
Articles

Don’t miss out on the EPO’s new fee reductions for micro entities

Getting a patent granted for your innovation can be a costly process. There are, of course, fees associated with the work your patent attorneys do to advise you, to prepare your patent application, and to work with the Patent Office to obtain a granted patent for you. 

Read more
Articles

Biological deposits for patents, the Five “W”s: Why, What, Where, When and Who?

Rachel Mercer discusses how biological deposits can be used to fulfil the requirements of a sufficient disclosure for patent applications involving biological material.

Read more
1 2 7 8 9 28 29
Skip to content